Honey and a Mixture of Honey, Beeswax and Olive Oil-propolis Extract in Treatment of Chemotherapy-induced Oral Mucositis

Sponsor
mamdouh abdulmaksoud abdulrhman (Other)
Overall Status
Completed
CT.gov ID
NCT01431729
Collaborator
(none)
90
1
13
6.9

Study Details

Study Description

Brief Summary

Although, oral mucositis has been studied for many years, no available treatment has been shown to be effective in preventing or treating mucositis. Based on the observations that honey and other products of honeybees have anti-inflammatory, anti-oxidant, anti-microbial and wound healing effects, the present study aims at evaluation of the effect of topical application of honey and a mixture of honey, beeswax and olive oil-propolis extract, as natural products, in treatment of chemotherapy-induced oral mucositis in children with acute lymphoblastic leukemia (ALL). This is a randomised controlled clinical trial in which eligible patients were randomly assigned into three equal treatment groups. Group 1 received 15 gm honey applied topically to the affected oral mucosa three times daily. Group 2 received 5 gm of a mixture of honey, olive oil-propolis extract and bees wax (HOPE) applied topically to the oral mucosa three times daily. Group 3 served as control and received a 7.5% benzocaine gel applied to the areas of ulcers three times daily.

Condition or Disease Intervention/Treatment Phase
  • Other: honey, hope,mucositis

Detailed Description

All patients with ALL during the consolidation phase of treatment, and with chemotherapy-related oral mucositis grades 2 and 3 were candidates for this trial.Exclusion criteria included the presence of any of the following: (1) coexisting diabetes mellitus, (2) administration of antiviral, antifungal therapy and / or any other treatment for oral mucositis before enrollment in the study, (3) presence of neutropenia (absolute neutrophilic count [ANC] ≤ 1500/mm3), (4) presence of advanced or severe periodontitis (patients with periodontal pockets of 6 mm or more. The primary outcome measure was the "recovery time", defined as the number of days from initiation of treatment to when complete healing of all ulcers occurred.

Study Design

Study Type:
Observational
Actual Enrollment :
90 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Honey and a Mixture of Honey, Beeswax and Olive Oil-propolis Extract in Treatment of Chemotherapy-induced Oral Mucositis: a Randomized Controlled Pilot Study
Study Start Date :
Jun 1, 2010
Actual Primary Completion Date :
Jun 1, 2011
Actual Study Completion Date :
Jul 1, 2011

Arms and Interventions

Arm Intervention/Treatment
mucositis

Other: honey, hope,mucositis
Eligible patients were randomly allocated by a computer-generated list of random numbers to be assigned into one of three treatment groups; Group (1) received an empirical dose of 15 gm honey applied topically to the affected oral mucosa three times daily until healing or for 10 days, which ever comes first. Group (2) received an empirical dose of 5 gm of a 4:2:1 mixture of honey, olive oil-propolis extract and beeswax (HOPE) applied topically to the oral mucosa three times daily until healing or for 10 days, which ever comes first. Group (3) served as controls and received benzocaine 7.5% gel applied topically to areas of ulcers three times daily.
Other Names:
  • honey,propolis,olive oil, mucositis
  • Outcome Measures

    Primary Outcome Measures

    1. "Recovery time" , defined as the number of days from initiation of treatment to when complete healing of all ulcers will occur. [10 days]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All patients with ALL during the consolidation phase of treatment, and

    • with chemotherapy-related oral mucositis grades 2 and 3

    Exclusion Criteria:
    1. coexisting diabetes mellitus,

    2. administration of antiviral, antifungal therapy and / or any other treatment for oral mucositis before enrollment in the study,

    3. presence of neutropenia (absolute neutrophilic count [ANC] ≤ 1500/mm3),

    4. presence of advanced or severe periodontitis (patients with periodontal pockets of 6 mm or more)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hematology - Oncology, Children's Hospital, Ain Shams University Cairo Abbasia Egypt

    Sponsors and Collaborators

    • mamdouh abdulmaksoud abdulrhman

    Investigators

    • Principal Investigator: Mamdouh Abdulrhman, professor, professor

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    mamdouh abdulmaksoud abdulrhman, professor of pediatrics, faculty of medicine, ain shams university, Ain Shams University
    ClinicalTrials.gov Identifier:
    NCT01431729
    Other Study ID Numbers:
    • honey propolis 421
    First Posted:
    Sep 12, 2011
    Last Update Posted:
    Sep 21, 2011
    Last Verified:
    Sep 1, 2011
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 21, 2011